News & Events


Harmony Prenatal Test Now Performed in Taiwan by Phoebus Genetics

June 16, 2016 - Roche and Phoebus Genetics Offer Patients Access to Microarray-Based Non-Invasive Prenatal Testing


US insurance coverage for Harmony Prenatal Test from Roche expands to 200 million covered lives

May 2, 2016 - In-network status for non-invasive prenatal test now includes four largest national private health plans and Medi-Cal


New publication shows consistent clinical performance in screening common fetal trisomies with Harmony Prenatal Test

Nov. 3, 2015 – Roche and Ariosa Diagnostics, a global leader in non-invasive prenatal testing technology and maker of the Harmony™ Prenatal Test, today announced the results of a new clinical study on the company’s targeted cell-free DNA analysis using microarray quantitation which...


Ariosa's Harmony Prenatal Test now performed in Australia and UK at Sonic Healthcare laboratories

Oct. 13, 2015 - Roche and Ariosa Diagnostics, in conjunction with Australian company Sonic Healthcare, today announced that Sonic Healthcare has been granted a license to perform the Harmony Prenatal Test in its Australian and United Kingdom labs.


Ariosa grants licenses to laboratories to perform NIPT based on Harmony™ Prenatal Test technology

June 11, 2015 – Roche (SIX: RO, ROG; OTCQX:RHHBY). First wave of laboratories in Europe will conduct Harmony Prenatal Test in their own labs


Ariosa receives CE mark for its FORTE Software to support HarmonyTM Prenatal Test

June 11, 2015 – Roche (SIX: RO, ROG; OTCQX:RHHBY) Ariosa Diagnostics, Inc., a global leader in non-invasive prenatal testing (NIPT), today announced its proprietary FORTE™ software has received the CE mark (Conformité Européenne).

« Précédent 123456...9 Suivant »